Owen Catherine E.
- SEC CIK
- 0001816838
In the past year, 1 open-market sale filing worth $249.9K and no purchases.
Current role at each company
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 23, 2026
- ACAD Acadia Pharmaceuticals IncChief Executive Officeras of Mar 26, 2026
- OPTN OptiNose, Inc.Directoras of Jun 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $249.9K
- 1 filing
- Net
- −$249.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Owen Catherine E. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACAD Acadia Pharmaceuticals Inc
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 26, 2026 (view filing) | Mar 25 | 1 day | Owen Catherine E.Chief Executive Officer | SSale | −11.6K | $21.47 | −$249.9K | −44.0%14.8K after |